MedPath

珠海亿邦制药有限责任公司

Ownership
-
Established
2003-09-28
Employees
-
Market Cap
-
Website
http://www.eb-zy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

20

NMPA:20

Drug Approvals

Voriconazole for Injection

Product Name
注射用伏立康唑
Approval Number
国药准字H20247019
Approval Date
Nov 1, 2024
NMPA

Nicergoline for Injection

Product Name
注射用尼麦角林
Approval Number
国药准字H20093146
Approval Date
Jan 2, 2024
NMPA

Ribostamycin Sulfate for Injection

Product Name
注射用硫酸核糖霉素
Approval Number
国药准字H20093547
Approval Date
Dec 18, 2023
NMPA

Ribostamycin Sulfate for Injection

Product Name
注射用硫酸核糖霉素
Approval Number
国药准字H20093548
Approval Date
Dec 18, 2023
NMPA

Norfloxacin Lactate for Injection

Product Name
注射用乳酸诺氟沙星
Approval Number
国药准字H20080575
Approval Date
Nov 27, 2023
NMPA

Norfloxacin Lactate for Injection

Product Name
注射用乳酸诺氟沙星
Approval Number
国药准字H20080577
Approval Date
Nov 27, 2023
NMPA

Nicergoline for Injection

Product Name
注射用尼麦角林
Approval Number
国药准字H20093145
Approval Date
Nov 21, 2023
NMPA

Compound Mannitol Injection

Product Name
复方甘露醇注射液
Approval Number
国药准字H20060576
Approval Date
May 6, 2020
NMPA

Aminobutyric Acid for Injection

Product Name
注射用氨酪酸
Approval Number
国药准字H20060245
Approval Date
May 6, 2020
NMPA

Pefloxacin Mesylate for Injection

Product Name
注射用甲磺酸培氟沙星
Approval Number
国药准字H20057417
Approval Date
Apr 21, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.